/UPDATED RELEASE -- SuperGen, Inc./
November 07 2008 - 9:01PM
PR Newswire (US)
In the news release, SuperGen (Nasdaq: SUPG) to Present at the
Rodman & Renshaw 10th Annual Healthcare Conference on November
10, 2008, issued on Monday, November 3 by SuperGen, Inc. over PR
Newswire, we are advised by a representative of the company that
SuperGen's presentation time has changed. The second paragraph,
first sentence, should now read, "SuperGen's presentation at the
Rodman & Renshaw 10th Annual Healthcare Conference is scheduled
to begin at 12:00 p.m. EST (9:00 a.m. PST)" rather than, "11:35
a.m. EST (8:35 a.m. PST)" as originally issued inadvertently. The
complete, corrected release follows: DUBLIN, Calif., Nov 3
/PRNewswire-FirstCall/ -- SuperGen, Inc. (NASDAQ: SUPG), a
pharmaceutical company dedicated to the discovery and development
of novel cancer therapies, today announced that James S. Manuso,
Ph.D., President and Chief Executive Officer, is scheduled to
present at the Rodman & Renshaw 10th Annual Healthcare
Conference on Monday, November 10, 2008, at the New York Palace
Hotel. SuperGen's presentation at the Rodman & Renshaw 10th
Annual Healthcare Conference is scheduled to begin at 12:00 p.m.
EST (9:00 a.m. PST). A live webcast of the presentation will be
available on the investor relations section of the Company's Web
site at http://www.supergen.com/. The webcast will be archived for
90 days. About SuperGen Based in Dublin, Calif., SuperGen, Inc. is
a pharmaceutical company dedicated to the discovery and development
of novel cancer therapies. SuperGen is developing a number of
therapeutic anticancer products focused on kinase and cell
signaling inhibitors and DNA methyltransferase inhibitors. For more
information about SuperGen, please visit http://www.supergen.com/.
Contacts: SuperGen, Inc. Timothy L. Enns SVP, Corporate
Communications & Business Development Tel: (925) 560-2810
Email: Dorland Global Public Relations Michael Beckerich (Media)
Tel: (212) 677-7632 DATASOURCE: SuperGen, Inc. CONTACT: Timothy L.
Enns, SVP of Corporate Communications & Business Development of
SuperGen, Inc., +1-925-560-2810, , or Michael Beckerich of Dorland
Global Public Relations, +1-212-677-7632, Web site:
http://www.supergen.com/
Copyright